Patents by Inventor Ingo Tamm

Ingo Tamm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of Hepatitis B X-Interacting Protein (HBXIP) in Modulation of Apoptosis
    Publication number: 20100190195
    Abstract: Novel methods of regulating cellular apoptosis by affecting the interaction of hepatitis B X-interacting protein (HBXIP) with Survivin are described. More specifically, these novel methods of enhancing apoptosis of neoplastic cells comprises inhibiting interaction of hepatitis B X-interacting protein (HBXIP) with Survivin using siRNA or antisense compounds.
    Type: Application
    Filed: February 2, 2010
    Publication date: July 29, 2010
    Inventors: Ingo Tamm, John C. Reed
  • Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis
    Patent number: 7655634
    Abstract: Novel methods of regulating cellular apoptosis by affecting the interaction of hepatitis B X-interacting protein (HBXIP) with Survivin are described. More specifically, these novel methods of enhancing apoptosis of neoplastic cells comprises inhibiting interaction of hepatitis B X-interacting protein (HBXIP) with Survivin using siRNA or antisense compounds.
    Type: Grant
    Filed: March 26, 2007
    Date of Patent: February 2, 2010
    Assignee: The Burnham Institute
    Inventors: Ingo Tamm, John C. Reed
  • Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis
    Patent number: 7393666
    Abstract: Novel methods of regulating cellular apoptosis by affecting the interaction of hepatitis B X-interacting protein (HBXIP) with Survivin are described. More specifically, these novel methods of enhancing apoptosis of neoplastic cells comprises inhibiting interaction of hepatitis B X-interacting protein (HBXIP) with Survivin.
    Type: Grant
    Filed: May 24, 2006
    Date of Patent: July 1, 2008
    Assignee: Burnham Institute for Medical Research
    Inventors: Ingo Tamm, John C. Reed
  • USE OF HEPATITIS B X-INTERACTING PROTEIN (HBXIP) IN MODULATION OF APOPTOSIS
    Publication number: 20070270369
    Abstract: Novel methods of regulating cellular apoptosis by affecting the interaction of hepatitis B X-interacting protein (HBXIP) with Survivin are described. More specifically, these novel methods of enhancing apoptosis of neoplastic cells comprises inhibiting interaction of hepatitis B X-interacting protein (HBXIP) with Survivin using siRNA or antisense compounds.
    Type: Application
    Filed: March 26, 2007
    Publication date: November 22, 2007
    Applicant: The Burnham Institute
    Inventors: Ingo Tamm, John Reed
  • Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis
    Publication number: 20060205008
    Abstract: Novel methods of regulating cellular apoptosis by affecting the interaction of hepatitis B X-interacting protein (HBXIP) with Survivin are described. More specifically, these novel methods of enhancing apoptosis of neoplastic cells comprises inhibiting interaction of hepatitis B X-interacting protein (HBXIP) with Survivin.
    Type: Application
    Filed: May 24, 2006
    Publication date: September 14, 2006
    Inventors: Ingo Tamm, John Reed
  • Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis
    Publication number: 20040138119
    Abstract: Novel methods of regulating cellular apoptosis by affecting the interaction of hepatitis B X-interacting protein (HBXIP) with Survivin are described. More specifically, these novel methods of enhancing apoptosis of neoplastic cells comprises inhibiting interaction of hepatitis B X-interacting protein (HBXIP) with Survivin.
    Type: Application
    Filed: September 18, 2003
    Publication date: July 15, 2004
    Inventors: Ingo Tamm, John C. Reed